User profiles for "author:F Giorgini"

Flaviano Giorgini

Professor of Neurogenetics, University of Leicester
Verified email at le.ac.uk
Cited by 16720

The kynurenine pathway and neurodegenerative disease

DC Maddison, F Giorgini - Seminars in cell & developmental biology, 2015 - Elsevier
Neuroactive metabolites of the kynurenine pathway (KP) of tryptophan degradation have
been closely linked to the pathogenesis of several neurodegenerative diseases. Tryptophan …

Yeast as a model for studying human neurodegenerative disorders

L Miller‐Fleming, F Giorgini… - Biotechnology Journal …, 2008 - Wiley Online Library
Protein misfolding and aggregation are central events in many disorders including several
neurodegenerative diseases. This suggests that alterations in normal protein homeostasis …

[HTML][HTML] DJ-1 in Parkinson's disease: clinical insights and therapeutic perspectives

M Repici, F Giorgini - Journal of clinical medicine, 2019 - mdpi.com
Mutations in the protein DJ-1 cause autosomal recessive forms of Parkinson's disease (PD)
and oxidized DJ-1 is found in the brains of idiopathic PD individuals. While several functions …

[HTML][HTML] Kynurenine 3-monooxygenase inhibition in blood ameliorates neurodegeneration

…, T Wu, K Scearce-Levie, C Patrick, A Adame, F Giorgini… - Cell, 2011 - cell.com
Metabolites in the kynurenine pathway, generated by tryptophan degradation, are thought to
play an important role in neurodegenerative disorders, including Alzheimer's and …

A genomic screen in yeast implicates kynurenine 3-monooxygenase as a therapeutic target for Huntington disease

F Giorgini, P Guidetti, QV Nguyen, SC Bennett… - Nature …, 2005 - nature.com
Huntington disease is a fatal neurodegenerative disorder caused by expansion of a
polyglutamine tract in the protein huntingtin (Htt), which leads to its aggregation in nuclear …

[PDF][PDF] The kynurenine pathway modulates neurodegeneration in a Drosophila model of Huntington's disease

…, PJ Muchowski, R Schwarcz, CP Kyriacou, F Giorgini - Current Biology, 2011 - cell.com
Neuroactive metabolites of the kynurenine pathway (KP) of tryptophan degradation have
been implicated in the pathophysiology of neurodegenerative disorders, including …

Glycation potentiates α-synuclein-associated neurodegeneration in synucleinopathies

…, S Engelender, M Zweckstetter, J Klucken, F Giorgini… - Brain, 2017 - academic.oup.com
α-Synuclein misfolding and aggregation is a hallmark in Parkinson's disease and in several
other neurodegenerative diseases known as synucleinopathies. The toxic properties of α …

[HTML][HTML] DJ-1 interactions with α-synuclein attenuate aggregation and cellular toxicity in models of Parkinson's disease

…, C Betzer, KR Straatman, PH Jensen, F Giorgini… - Cell death & …, 2014 - nature.com
Parkinson's disease (PD) is a devastating neurodegenerative disorder characterized by the
loss of neurons in the substantia nigra pars compacta and the presence of Lewy bodies in …

Tryptophan-2, 3-dioxygenase (TDO) inhibition ameliorates neurodegeneration by modulation of kynurenine pathway metabolites

…, CP Kyriacou, R Schwarcz, F Giorgini - Proceedings of the …, 2016 - National Acad Sciences
Metabolites of the kynurenine pathway (KP) of tryptophan (TRP) degradation have been
closely linked to the pathogenesis of several neurodegenerative disorders. Recent work has …

[HTML][HTML] Mutant huntingtin impairs immune cell migration in Huntington disease

…, R Andre, A Miller, A Weiss, F Giorgini… - The Journal of …, 2012 - Am Soc Clin Investig
In Huntington disease (HD), immune cells are activated before symptoms arise; however, it
is unclear how the expression of mutant huntingtin (htt) compromises the normal functions of …